Patents Assigned to Reed MacFadden, Ltd.
  • Patent number: 5686417
    Abstract: A composition useful in treating Multiple Sclerosis and HTLV-1 myelopathy in humans comprises:i) a peptide having as its active portion, an amino acid sequence of the formula:-Thr-Thr-Asn-Tyr-Thr-; andii) a pharmaceutically acceptable carrier for said peptide.
    Type: Grant
    Filed: November 8, 1995
    Date of Patent: November 11, 1997
    Assignee: Reed MacFadden, Ltd.
    Inventors: Douglas K. MacFadden, Peter L. Carlen, Penelope Reed Doob